BioWorld Science delivers discovery and preclinical research news to support crucial drug R&D decisions at the earliest stages every business day. On this site, you’ll find that the lead article is freely available. The rest of the daily headlines link back to the legacy site. If you’re a subscriber, click on any headline and you’ll be taken back to the original site, which is still active. For more about BioWorld Science, click here.